Eric E. Boros - Concepedia

Author

Eric E. Boros

Research Triangle Park Foundation

Also Known As

Boros, Eric E., E BOROS, E. E. BOROS, E.E. Boros, Eric Boros, Eric E. Boros, Eric E. Boros

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Virginia Tech Shionogi (Japan)Cornell University

About

Eric E. Boros is an author at Research Triangle Park Foundation specializing in pharmacology, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	15	18	597
2	Medicine	13	14	587
3	Engineering	12	12	319
4	Health Sciences	3	3	130
5	Anesthesia	1	1	29

Eric E. Boros

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Tumor Necrosis Factor-induced Cell Death in MCF7 by a Novel Inhibitor of Neutral Sphingomyelinase Chiara Luberto, Daniel F. Hassler, Paola Signorelli, Journal of Biological Chemistry	2002	325
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors Curt D. Haffner, J. David Becherer, Eric E. Boros, Journal of Medicinal Chemistry Antiparasitic AgentNad LevelsPharmacotherapyMedicinal ChemistryNad Elevation	2015	127
Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes Yulin Wu, Christopher Aquino, David J. Cowan, Journal of Medicinal Chemistry Molecular PharmacologyMetabolic SyndromeLipid SynthesisBiochemistryBiliary Tract	2013	79
The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral Edward P. Garvey, Brian A. Johns, Margaret Gartland, Antimicrobial Agents and Chemotherapy Naphthyridinone Gsk364735MedicineHuman RetrovirusImmunologyAntiviral Drug Development	2007	74
New diol metabolites derived by biooxidation of chlorostyrenes with Pseudomonas putida: Determination of absolute stereochemistry and enantiomeric excess by convergent syntheses Tomáš Hudlický, Eric E. Boros, Christie Boros Tetrahedron Asymmetry EngineeringBiochemistryNatural SciencesBiocatalysisSecondary Metabolite	1993	52
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38 J. David Becherer, Eric E. Boros, Tiffany Carpenter, Journal of Medicinal Chemistry PharmacotherapyChemical BiologyExperimental PharmacologyPharmaceutical ChemistryTranslational Pharmacology	2015	52
Preclinical Pharmacology of GW280430A (AV430A) in the Rhesus Monkey and in the Cat John J. Savarese, Matthew R. Belmont, Mir A. Hashim, Anesthesiology	2004	51
A Model Study Directed Towards a Practical Enantioselective Total Synthesis of (-)-Morphine Tomáš Hudlický, Christie Boros, Eric E. Boros Synthesis Combinatorial ChemistryStereogenic CentersBioorganic ChemistryEngineeringOrganic Chemistry	1992	43
Synthesis and HIV-integrase strand transfer inhibition activity of 7-hydroxy[1,3]thiazolo[5,4-b]pyridin-5(4H)-ones Eric E. Boros, Brian A. Johns, Edward P. Garvey, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineHivPharmacologyAntiviral Compound	2006	43
Synthesis of Ultra-Short-Acting Neuromuscular Blocker GW 0430: A Remarkably Stereo- and Regioselective Synthesis of Mixed Tetrahydroisoquinolinium Chlorofumarates Vicente Sámano, John A. Ray, James B. Thompson, Organic Letters Stereoselective CrystallizationEngineeringOrganic ChemistryChemistryChemical Biology	1999	41

Page 1